《全日速报》恒指全日收报28,412点 跌46点; 恒生科技指数全日收报7,876点 跌148点 京东健康跌逾6% 石药、复星旅游文化、康宁杰瑞制药、康方生物、神威药业创新高 成交畅旺
恒指全日收28,412点,跌46点或0.2%。恒生科技指数报7,876点,跌148点或1.9%。国指跌61点或0.6%,报10,641点。大市成交额1,208.85亿元。
活跃重磅股表现:
美团(03690.HK) 收271元,下跌1.5%;
阿里巴巴(09988.HK) 收205元,下跌1.4%;
港交所(00388.HK) 收450.4元,下跌0.7%;
建行(00939.HK) 收6.18元,上升0.3%;
腾讯(00700.HK) 收585.5元,下跌0.2%;
友邦(01299.HK) 收101.5元,下跌0.2%;
平安(02318.HK) 收81.3元,下跌0.1%;
异动恒指及国指成份股:
京东健康(06618.HK) 收111元,下跌6.3%;
翰森制药(03692.HK) 收33.1元,下跌5.4%;
石药(01093.HK) 收11.56元,上升4.4%,创新高;
网易(09999.HK) 收179.8元,下跌4%;
创科(00669.HK) 收140.4元,上升3.3%;
中生制药(01177.HK) 收9.05元,上升3.2%;
快手-W(01024.HK) 收232.2元,下跌3.2%;
异动综合中小型股:
复星旅游文化(01992.HK) 收15.16元,上升13.8%,创新高;
康宁杰瑞制药(09966.HK) 收24.45元,上升13.7%,创新高;
康方生物(09926.HK) 收62.9元,上升10.3%,创新高;
神威药业(02877.HK) 收8.01元,上升3.9%,创新高;
~
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.